ag-1296 has been researched along with cyc 202 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Colanesi, S; Ishizaki, H; Kelsh, RN; Liu, D; Lundegaard, PR; North, TE; Patton, EE; Taylor, KL; Temperley, ND | 1 |
2 other study(ies) available for ag-1296 and cyc 202
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Small molecule screening identifies targetable zebrafish pigmentation pathways.
Topics: Animals; Cell Count; Chromatophores; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Embryo, Nonmammalian; Heterocyclic Compounds, 3-Ring; Melanocytes; Metabolic Networks and Pathways; Phenotype; Pigmentation; Purines; Pyrimidinones; Roscovitine; Small Molecule Libraries; Tyrphostins; Zebrafish | 2012 |